tiprankstipranks

Christopher Morabito Insider Profile

4 Followers
Christopher Morabito, CMO at Fulcrum Therapeutics, holds 0.00 shares in Astria Therapeutics (Ticker: ATXS), holds 1.10K shares in Fulcrum Therapeutics (Ticker: FULC).
tipranks
Christopher Morabito

Christopher Morabito
Fulcrum Therapeutics (FULC)
CMO

Not Ranked
Christopher Morabito has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$3K
100.00%
0.00%
A breakdown of Christopher Morabito's holdings

Insider Roles

Fulcrum Therapeutics
(FULC)
CMO
Astria Therapeutics
(ATXS)
CMO
Roles that Christopher Morabito holds in companies

Most Profitable Insider Trade

Stock:
Fulcrum Therapeutics
(FULC)
Rating:Informative Buy
Date:Jun 29, 2021 - Jun 29, 2022
Return:-47.90%
The most profitable trade made by Christopher Morabito

Christopher Morabito's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Fulcrum Therapeutics
Jun 29, 2021
CMO
Informative Buy
10.08K
$3.29K
Astria Therapeutics
Apr 03, 2024
CMO
Uninformative Buy
38.70K
$0.00
List of latest transactions for each holding click on a transaction to see Christopher Morabito's performance on stock

Christopher Morabito insider profile FAQ

What is the percentage of profitable transactions made by Christopher Morabito?
The percentage of profitable transactions made by Christopher Morabito is ―.
    What is the average return per transaction made by Christopher Morabito?
    The average return per transaction made by Christopher Morabito is ―.
      What stocks does Christopher Morabito hold?
      Christopher Morabito holds: FULC, ATXS stocks.
        What was Christopher Morabito’s latest transaction?
        Christopher Morabito latest transaction was an Uninformative Buy of $38.70K.
          What was Christopher Morabito's most profitable transaction?
          Christopher Morabito’s most profitable transaction was an Informative Buy of FULC stock on June 29, 2021. The return on the trade was -47.90%.
            What is Christopher Morabito's role in Fulcrum Therapeutics?
            Christopher Morabito's role in Fulcrum Therapeutics is CMO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.